Literature DB >> 27314418

Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.

Shiro Ishihara1,2, Etienne Gayat2,3,4, Naoki Sato1, Mattia Arrigo2,4,5, Said Laribi2,3,6, Matthieu Legrand2,3,4, Rui Placido2,7, Philippe Manivet2,8,9, Alain Cohen-Solal2,3,10, William T Abraham11, Mariell Jessup12, Alexandre Mebazaa13,14,15.   

Abstract

BACKGROUND: Acute heart failure (AHF) with reduced left-ventricular ejection fraction (LVEF) is often a biventricular congested state. The comparative effect of vasodilators and inotropes on the right- and/or left-sided congestion is unknown. METHODS AND
RESULTS: A systematic review, meta-analysis, and meta-regression of AHF studies using pulmonary artery catheter were performed using PubMed, Embase, and Cochrane library. Data from 35 studies, including 3016 patients, were studied. Included patients had a weighted mean age of 60 years, left-ventricular ejection fraction (LVEF) of 24 %, and plasma B-type natriuretic peptide (BNP) of 892 pg/ml. Both the left- and right-ventricular filling pressures were elevated: weighted mean pulmonary artery wedge pressure (PAWP) was 25 mmHg (range 17-31 mmHg) and right atrial pressure (RAP) 12 mmHg (range 7-18 mmHg). Vasodilators and inotropes had similar beneficial effects on PAWP [-6.3 mmHg (95 % CI -7.4 to -5.2 mmHg) and -5.8 mmHg (95 % CI -7.6 to -4.0 mmHg), respectively] and RAP [-2.9 mmHg (95 % CI -3.8 to -2.1 mmHg) and -2.8 mmHg (95 % CI -3.8 to -1.7 mmHg), respectively]. Among inotropes, inodilators, such as levosimendan, have greater beneficial effect on the left-ventricular filling pressure than dobutamine. Drug-induced improvement of PAWP tightly paralleled that of RAP with all studied drugs (r 2 = 0.90, p < 0.001). Vasodilators and inotropes had no short-term effect of renal function.
CONCLUSION: The left- and right-sided filling pressures are similarly improved by vasodilators or inotropes, in AHF with reduced LVEF.

Entities:  

Keywords:  Acute heart failure; Congestion; Decongestion; Hemodynamics; Inotropes; Meta-analysis; Meta-regression; Vasodilators

Mesh:

Substances:

Year:  2016        PMID: 27314418     DOI: 10.1007/s00392-016-1009-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  45 in total

1.  Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.

Authors:  Erland Erdmann; Marc J Semigran; Markku S Nieminen; Mihai Gheorghiade; Rahul Agrawal; Veselin Mitrovic; Alexandre Mebazaa
Journal:  Eur Heart J       Date:  2012-07-09       Impact factor: 29.983

2.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.

Authors:  Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne W Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

3.  Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside.

Authors:  M A Fifer; W S Colucci; B H Lorell; B E Jaski; W H Barry
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

4.  Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.

Authors:  M T Slawsky; W S Colucci; S S Gottlieb; B H Greenberg; E Haeusslein; J Hare; S Hutchins; C V Leier; T H LeJemtel; E Loh; J Nicklas; D Ogilby; B N Singh; W Smith
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

5.  Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.

Authors:  Mihai Gheorghiade; Stephen J Greene; Gerasimos Filippatos; Erland Erdmann; Roberto Ferrari; Phillip D Levy; Aldo Maggioni; Christina Nowack; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2012-06-19       Impact factor: 15.534

6.  A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure.

Authors:  Justin L Grodin; Mark H Drazner; Matthias Dupont; Wilfried Mullens; David O Taylor; Randall C Starling; W H Wilson Tang
Journal:  Am Heart J       Date:  2015-02-28       Impact factor: 4.749

7.  Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.

Authors:  Keiji Tanaka; Kazuzo Kato; Teruo Takano; Takashi Katagiri; Hidetsugu Asanoi; Jun Nejima; Mitsuyoshi Nakashima; Takeshi Kamijo; Matao Sakanashi
Journal:  J Cardiol       Date:  2010-08-14       Impact factor: 3.159

8.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors:  W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

9.  Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.

Authors:  Mihai Gheorghiade; John E A Blair; Gerasimos S Filippatos; Cezar Macarie; Witold Ruzyllo; Jerzy Korewicki; Serban I Bubenek-Turconi; Maurizio Ceracchi; Maria Bianchetti; Paolo Carminati; Dimitrios Kremastinos; Giovanni Valentini; Hani N Sabbah
Journal:  J Am Coll Cardiol       Date:  2008-04-09       Impact factor: 24.094

10.  Sodium nitroprusside for advanced low-output heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; Hadi N Skouri; Randall C Starling; James B Young; David O Taylor; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

View more
  18 in total

1.  Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort.

Authors:  Tahar Chouihed; Patrick Rossignol; Adrien Bassand; Kévin Duarte; Masatake Kobayashi; Déborah Jaeger; Sonia Sadoune; Aurélien Buessler; Lionel Nace; Gaetan Giacomin; Thibaut Hutter; Françoise Barbé; Sylvain Salignac; Nicolas Jay; Faiez Zannad; Nicolas Girerd
Journal:  Clin Res Cardiol       Date:  2018-10-28       Impact factor: 5.460

2.  Prognostic value of estimated plasma volume in acute heart failure in three cohort studies.

Authors:  Masatake Kobayashi; Patrick Rossignol; João Pedro Ferreira; Irene Aragão; Yuki Paku; Yoichi Iwasaki; Masataka Watanabe; Marat Fudim; Kevin Duarte; Faiez Zannad; Nicolas Girerd
Journal:  Clin Res Cardiol       Date:  2018-10-19       Impact factor: 5.460

3.  What's new in cardiorenal syndrome?

Authors:  Michael Darmon; Miet Schetz
Journal:  Intensive Care Med       Date:  2018-04-26       Impact factor: 17.440

Review 4.  Cardiorenal Interactions Revisited: How to Improve Heart Failure Outcomes in Patients With Chronic Kidney Disease.

Authors:  Mattia Arrigo; Pietro E Cippà; Alexandre Mebazaa
Journal:  Curr Heart Fail Rep       Date:  2018-10

5.  Noninvasive pulse contour analysis for determination of cardiac output in patients with chronic heart failure.

Authors:  Sebastian Roth; Henrik Fox; Uwe Fuchs; Uwe Schulz; Angelika Costard-Jäckle; Jan F Gummert; Dieter Horstkotte; Olaf Oldenburg; Thomas Bitter
Journal:  Clin Res Cardiol       Date:  2018-01-19       Impact factor: 5.460

6.  Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.

Authors:  Dimitrios Farmakis; Panagiotis Simitsis; Vasiliki Bistola; Filippos Triposkiadis; Ignatios Ikonomidis; Spyridon Katsanos; George Bakosis; Erifili Hatziagelaki; John Lekakis; Alexandre Mebazaa; John Parissis
Journal:  Clin Res Cardiol       Date:  2016-12-20       Impact factor: 5.460

Review 7.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

Review 8.  Blood Pressure Reduction in Hypertensive Acute Heart Failure.

Authors:  Nicholas Harrison; Peter Pang; Sean Collins; Phillip Levy
Journal:  Curr Hypertens Rep       Date:  2021-02-20       Impact factor: 5.369

9.  Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Authors:  Gad Cotter; Beth A Davison; Javed Butler; Sean P Collins; Justin A Ezekowitz; G Michael Felker; Gerasimos Filippatos; Phillip D Levy; Marco Metra; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Stefanie Senger; David Bharucha; Kathleen Goin; David G Soergel; Peter S Pang
Journal:  Clin Res Cardiol       Date:  2017-10-06       Impact factor: 5.460

Review 10.  Optimising Heart Failure Therapies in the Acute Setting.

Authors:  Mattia Arrigo; Petra Nijst; Alain Rudiger
Journal:  Card Fail Rev       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.